April 4th 2020 - Dr. Fred Buckhold, Mike Ferguson, Dr. Sarah George, Dr. Jeffrey Henderson, & Dr. Alfred Kim

Health Matters
Saturday, April 4th
Dr. FRED BUCKHOLD, SLU Care general internist with SSM Health Saint Louis University Hospital.  The White House is about to announce a voluntary universal policy for people to wear face coverings when going out in public.  Dr. Buckhold isn't a big proponent of this but says it couldn't hurt.  He says social distancing is much more effective.  He fears masks will become even more in short supply for those who need it most -- healthcare professionals and those who are sick.  Also says wearing gloves will not help you much and could actually help spread the disease.  He suggests just good hand washing.  And he says he favors a national stay at home policy.

MIKE FERGUSON, Entercom St. Louis talk show host.  Mike is recovering from COVID-19.  When and how did he get it?  How did he know? What were his symptoms? Why did he go to the hospital?  What was his treatment?  How is he doing now? Did he infect anyone close to him? Was he at high risk?  What's his message for the rest of us?

Dr. SARAH GEORGE, SLU Care infectious diseases specialist at Saint Louis University School of Medicine.  Saint Louis University researchers are studying a possible therapy to treat COVID-19.  The drug is called Remdesivir.  It is an investigational intravenous anti-viral medication.  To be eligible, you must be 18 and hospitalized with a positive case of COVID-19 at Saint Louis University Hospital.  How does it work?  Has it worked in other viral cases?

Dr. JEFFREY HENDERSON, professor of medicine and molecular microbiology at Washington University School of Medicine.  Wash U is researchers are investigating a possible COVID-19 treatment: the transfusion of antibodies from the blood of patients who have recovered from COVID-19.  Their blood is then given to patients who either are at risk of getting coronavirus or have an early case of it.  They are putting together the donor registry now.

Dr. ALFRED KIM, rheumatologist and co director of the Washington University Lupus Clinic.  Dr. Kim tells us that there continues to be a shortage of the drug hydroxychloroquine and chloroquine -- which is critically needed for Lupus and rheumatoid arthritis patients -- but doctors are hoarding it because it is a possible treatment for COVID-19.   Dr. Kim says this must stop and he has some suggestions on how to fix the problem.